Vaccines have transformed modern medicine, yet their impact hinges on a behind-the-scenes hero: analytical development. This process ensures every dose meets strict safety and efficacy benchmarks, from early design to global distribution.Read More…
In a recent study, the California Institute of Technology’s novel technology seeks to develop more effective vaccines, starting with SARS-CoV-2, the coronavirus that causes COVID-19. In mouse studies, this prototype vaccine producedRead More…
A tool designed to detect the history of viral infection from a drop of blood has been upgraded in the COVID-19 era. VirScan is a technique that determines which of more thanRead More…
In a new study, researchers from the University of North Carolina at Chapel Hill and other research institutions have developed a new COVID-19 mouse model that reproduces many of the features ofRead More…
According to a new virological research paper published in Nature-structure and Molecular Biology, a professional academic journal of Springer Nature, through a comparative study on the structure of the novel coronavirus (SARS-CoV-2)Read More…
Mark Shotov, director of the “Vector” National Virology and Biotechnology Research Center of the Russian Federation’s Consumer Rights Protection and Public Welfare Supervision Agency, said the center had developed an intranasal novelRead More…
Recently, researchers have found that a Middle East respiratory syndrome coronavirus vaccine has shown efficacy in human trials, which may help to develop a vaccine against the new virus. Professor Marylyn Addo,Read More…
1. Introduction to COVID-19 Novel coronavirus (SARS-CoV-2) is a member of the enveloped RNA virus family, novel coronavirus, which was discovered at the end of 2019. This family of viruses includes MiddleRead More…